demonstrated that adipose‐derived MSCs induce EMT in ovarian cancer cells and activate the TGF‐β signaling pathway to enhance ovarian cancer growth and metastasis, an effect that can be reversed by the TGF‐β inhibitor SB431542. This evidence concerns the gene TGFB1 and ovarian carcinoma.